Gemma-Claire Ali (she/her) is an analyst at RAND Europe with seven years of professional experience in public health research, the last three of which have focused on the interface between health and emerging technologies. She specialises in the full breadth of literature review types and a wide range of qualitative research methods, including surveys, interviews, focus groups and case studies.
At RAND Europe, she has worked on several projects involving evidence synthesis to inform policymaking and strategy development in the fields of health and innovation. In particular, she has recently completed two large scoping reviews of digital innovations implemented in response to the COVID-19 pandemic, commissioned by the European Centre for Disease Prevention and Control (ECDC). This followed a broader scoping review of the use of emerging technologies for infectious disease surveillance, prevention and control, also commissioned by the ECDC.
Other relevant projects include understanding the impact of the COVID-19 pandemic on work-related musculoskeletal disorders, commissioned by the Health and Safety Executive, and a historical foresight study of antimicrobial resistance (AMR) commissioned by the AHRC. This last project drew on literature reviews, interviews, policy workshops and foresight methods to understand how AMR, tobacco control and climate change have developed as policy issues over time, and to inform future AMR policy.
She holds an M.A. in geography from the University of Cambridge, an M.Sc. from the London School of Hygiene & Tropical Medicine and King’s College London, and is completing her Ph.D. part-time at the University of Cambridge.